Dr. Regina Rabinovich Succeeds Dr. Axel Hoos as Sabin Vaccine Institute Board Chair, Drs. Norman Baylor and JoAnn Suzich Join the Board

Submitted by Greg Bodwell on

The Sabin Vaccine Institute (Sabin) is pleased to announce the Board of Trustees has unanimously elected Regina Rabinovich, MD, MPH, as board chair and elected two new trustees, Dr. Norman Baylor and Dr. JoAnn Suzich, to strengthen the organization’s leadership in global immunization and vaccine research and development.

Skoll Foundation Funds Sabin Vaccine Institute, Dalberg and JSI Research & Training Institute, Inc. to Establish COVID-19 Vaccine Equity Project

Submitted by Samia Kemal on

As COVID-19 vaccine developers generate clinical evidence of safety and effectiveness needed for vaccine approval, this project will help prepare for the efficient and equitable distribution of vaccines globally by ensuring that national immunization programs have the resources and health systems in place to achieve sustainable global protection from COVID-19 by 2022 and strengthen capacity for vaccination across the life span.

Professor Gordon Dougan Receives the 2020 Albert B. Sabin Gold Medal; Sabin Vaccine Institute’s New Rising Star Award Presented to Dr. Katherine E. Gallagher

Submitted by Samia Kemal on

Sabin today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge. Sabin also presented the inaugural Rising Star Award to Katherine E. Gallagher, MSc, PhD, assistant professor of epidemiology at the London School of Hygiene and Tropical Medicine.

Sabin's President of Global Immunization Dr. Bruce Gellin Testifies at House Briefing on Approval Processes for Safe, Effective COVID-19 Vaccine

Submitted by Samia Kemal on

Bruce Gellin, M.D., M.P.H., president of Global Immunization at the Sabin Vaccine Institute (Sabin) and former Deputy Assistant Secretary for Health and Director of the National Vaccine Program Office at the U.S. Department of Health and Human Services (HHS), testified on July, 14, 2020, at the House Subcommittee on Economic and Consumer Policy’s briefing entitled “Guardrails to Ensure a Safe and Effective COVID-19 Vaccine.”

Pages